mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0092 |
0.8 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.8 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.8 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0088 |
0.8 |
mRNA |
AZD0530 |
FIMM |
pan-cancer |
AAC |
-0.041 |
0.8 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0087 |
0.8 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.0091 |
0.8 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
0.071 |
0.8 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |